Parnax Lab Ltd
NSE: BSE: 506128
₹129.90
(-0.08%)
Mon, 16 Mar 2026, 06:33 am
Market Cap1.48B
PE Ratio11.90
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KParnax Lab Income Statement
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total revenue | 1.09B | 953.15M | 900.60M | 1.63B | 1.68B | 1.89B | 1.88B |
| Gross profit | 209.83M | 102.37M | 107.09M | 247.20M | 246.88M | 247.44M | 309.19M |
| Operating expenses (excl. COGS) | -140.53M | -79.06M | -57.35M | -70.90M | -80.07M | -80.59M | -110.83M |
| Selling/general/admin expenses, total | -144.78M | -80.11M | -57.63M | -71.04M | -79.12M | -81.47M | -111.47M |
| Research & development | — | — | — | 0 | 0 | — | — |
| Selling/general/admin expenses, other | -144.78M | -80.11M | -57.63M | -71.04M | -79.12M | -81.47M | -111.47M |
| Other operating expenses, total | 4.25M | 1.05M | 284.43K | 145.32K | -944.65K | 879.00K | 635.00K |
| Operating income | 69.30M | 23.31M | 49.75M | 176.31M | 166.81M | 166.84M | 198.35M |
| Non-operating income, total | -23.10M | -42.98M | -50.58M | -53.66M | -44.01M | -46.35M | -41.61M |
| Interest expense, net of interest capitalized | -38.88M | -46.02M | -50.81M | -52.30M | -49.51M | -53.46M | -53.91M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 15.78M | 3.04M | 227.43K | -1.36M | 6.14M | 6.69M | 12.29M |
| Non-operating interest income | 716.32K | 821.65K | 862.41K | 953.62K | 1.94M | 4.19M | 1.71M |
| Miscellaneous non-operating expense | 15.45M | 2.22M | -634.98K | -2.31M | 4.20M | 2.50M | 10.58M |
| Unusual income/expense | 0 | 0 | 0 | 0 | -638.50K | 423.00K | 0 |
| Pretax income | 46.20M | -19.67M | -837.49K | 122.64M | 122.80M | 120.50M | 156.74M |
| Taxes | -13.15M | -9.49M | -2.79M | -40.06M | -36.47M | -24.25M | -41.35M |
| Non-controlling/minority interest | -66.11K | 18.23K | -15.40K | -154.34K | -148.57K | -156.00K | -203.00K |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 32.99M | -29.14M | -3.64M | 82.43M | 86.18M | 96.09M | 115.19M |
| Net income | 32.99M | -29.14M | -3.64M | 82.43M | 86.18M | 96.09M | 115.19M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 32.99M | -29.14M | -3.64M | 82.43M | 86.18M | 96.09M | 115.19M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - |
| EBITDA | 107.53M | 67.90M | 101.34M | 234.96M | 232.10M | 236.49M | 272.13M |
| EBIT | 69.30M | 23.31M | 49.75M | 176.31M | 166.81M | 166.84M | 198.35M |
| Total operating expenses | -1.02B | -929.84M | -850.85M | -1.45B | -1.51B | -1.72B | -1.68B |
| Prepaid expenses | 10.02M | 19.69M | 26.00M | — | — | — | — |
| Deferred income, current | 8.33M | 5.48M | 976.76K | 48.10K | 1.82M | 588.00K | 6.98M |
| Capital and operating lease obligations | 0 | 31.55M | 31.55M | 31.56M | 33.11M | 82.54M | 82.54M |
| Operating lease liabilities | — | — | — | — | — | — | — |
| Deferred tax liabilities | 7.12M | 16.89M | 18.74M | 31.67M | 39.28M | 46.86M | 53.67M |
| Deferred income, non-current | — | — | — | — | — | — | — |
| Minority interest | 768.29K | 749.57K | 766.77K | 919.21K | 1.07M | 1.22M | 1.42M |
| Change in accrued expenses | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800